Owner of Insys Therapeutics charged with bribing doctors to prescribe powerful opioid spray
Dr. John N. Kapoor, the billionaire founder of Insys Therapeutics, was arrested and charged Thursday with bribing doctors to prescribe Subsys, a spray meant for cancer patients that contains the highly addictive synthetic opioid fentanyl.
Kapoor, 74, was arrested in Phoenix, and is facing federal charges of racketeering, conspiracy to commit fraud, and conspiracy to violate an anti-kickback law; the racketeering and fraud charges alone carry possible prison sentences of up to 20 years. Subsys was approved by the FDA to treat cancer patients who have pain that can't be helped by any other narcotics, and a 30-day supply costs between $3,000 and $30,000, NBC News reports; in the last year, Insys has sold $240 million worth of Subsys. Prosecutors allege Insys paid doctors hundreds of thousands of dollars in exchange for them prescribing Subsys, which is 100 times stronger than morphine.
Three of the top prescribers have been convicted of accepting bribes from Insys, and Insys denies any wrongdoing, saying the company cannot be held responsible for how doctors prescribe products. Over the summer, former employee and whistleblower Patty Nixon told NBC News she was trained to make sure doctors prescribed Subsys, even to patients who did not have cancer. She contacted insurance companies on behalf of the patients and doctors, she said, sometimes pretending to work for a doctor who treated cancer patients to make it easier for her requests to go through.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Zimbabwe’s driving crisisUnder the Radar Southern African nation is experiencing a ‘public health disaster’ with one of the highest road fatality rates in the world
-
The Mint’s 250th anniversary coins face a whitewashing controversyThe Explainer The designs omitted several notable moments for civil rights and women’s rights
-
‘If regulators nix the rail merger, supply chain inefficiency will persist’Instant Opinion Opinion, comment and editorials of the day
-
TikTok secures deal to remain in USSpeed Read ByteDance will form a US version of the popular video-sharing platform
-
Unemployment rate ticks up amid fall job lossesSpeed Read Data released by the Commerce Department indicates ‘one of the weakest American labor markets in years’
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
